Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Price:
7.9 USD
1.94%
Market Closed
Updated:
May 21, 2024
Allscripts Healthcare Solutions Inc
Cost of Revenue
|
Allscripts Healthcare Solutions Inc
Cost of Revenue Peer Comparison
Comparables:
VEEV
INSP
DOCS
CERT
GDRX
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
|
Cost of Revenue
-$431.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cost of Revenue
-$677.3m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-23%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cost of Revenue
-$101.5m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cost of Revenue
-$50.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Cost of Revenue
-$141m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cost of Revenue
-$66.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
See Also
What is Allscripts Healthcare Solutions Inc's Cost of Revenue?
Cost of Revenue
-431.8m
USD
-431.8m
USD
Based on the financial report for Sep 30, 2022, Allscripts Healthcare Solutions Inc's Cost of Revenue amounts to -431.8m USD.
What is Allscripts Healthcare Solutions Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
6%
6%
Over the last year, the Cost of Revenue growth was -4%. The average annual Cost of Revenue growth rates for Allscripts Healthcare Solutions Inc have been 25% over the past three years , 13% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
